Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Phase IV, Open-label, Randomized Clinical Trial on the Effect of Intravenous Iron on Quality of Life in Elderly Patients With Acute Coronary Syndrome
Authors not listed
Fundación para la Investigación del Hospital Clínico de Valencia · 2026
Abstract
The goal of this phase IV, open-label, randomized clinical trial is to evaluate whether intravenous iron improves quality of life in adults aged 65 years and older with iron deficiency after an acute coronary syndrome (ACS).
The main questions it aims to answer are:
* Does intravenous iron improve quality of life at 6 and 12 months?
* Does it reduce frailty and adverse clinical outcomes?
Researchers will compare intravenous ferric carboxymaltose with standard of care.
Participants will:
* Be randomly assigned to receive intravenous iron or standard care
* Attend three study visits over 12 months
* Complete questionnaires and undergo blood tests
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-03 MST
Cite this
APA
Anonymous. (2026). Phase IV, Open-label, Randomized Clinical Trial on the Effect of Intravenous Iron on Quality of Life in Elderly Patients With Acute Coronary Syndrome. <em>Fundación para la Investigación del Hospital Clínico de Valencia</em>. https://clinicaltrials.gov/study/NCT07476859
Vancouver
Anonymous. Phase IV, Open-label, Randomized Clinical Trial on the Effect of Intravenous Iron on Quality of Life in Elderly Patients With Acute Coronary Syndrome. Fundación para la Investigación del Hospital Clínico de Valencia. 2026.
BibTeX
@misc{anon2026PhaseI,
title = {Phase IV, Open-label, Randomized Clinical Trial on the Effect of Intravenous Iron on Quality of Life in Elderly Patients With Acute Coronary Syndrome},
author = {Anonymous},
journal = {Fundación para la Investigación del Hospital Clínico de Valencia},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Assistance Publique - Hôpitaux de Paris 2021
Open access · US-GOV
Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia: a Randomized Phase 3 Trial
University of Washington 2027
Open access · US-GOV
VOCALE: A Digital Intervention to Improve Quality of Life and Reduce Frailty Among Older Adults in CCRCs - A Randomized Controlled Trial
Zhejiang Hospital 2025
Open access · US-GOV
A Prospective, Double-blind, Randomized Controlled Clinical Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease
Yanbu Ke 2025
Open access · US-GOV
A Prospective, Double-blind, Randomized Controlled Clinical Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease
Technical University of Munich 2024
Open access · US-GOV
Effect Of Daily Taurine Supplementation For 6 Months On Biological Age and Metabolic Biomarkers As Well As Physical Fitness In 55-75-year-old Women And Men: A Randomized Controlled Intervention Study
Regional Specialist Hospital in Wroclaw 2026
Open access · US-GOV